SITC 2021 Booth #413

November 10-14, 2021

Advancing cancer and immunotherapy research with immunosequencing


The Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting (SITC 2021) provides a multidisciplinary educational and interactive environment focused on improving the outcome for current and future patients with cancer.

Adaptive is excited to be hosting a special symposium during the event, where we will be highlighting exciting research taking place across the cancer research landscape and how immune repertoire profiling with the immunoSEQ Technology is uniquely suited to answer questions related to immuno-oncology. If you are attending SITC in-person, we hope you’ll stop by booth #413 and connect.


Utilizing immunosequencing in cancer research and immunotherapy

Independence Ballroom at the Marriott Marquis Washington DC
Friday, November 12 | 1:30-2:30pm

Learn about immunoSEQ® and how our science plays a role in the solid tumor setting as well as transgenic T-cell receptor adoptive cell therapies.


Katie Boland, DVM, Ph.D.

Adaptive Biotechnologies

immunoSEQ® overview

Kellie N. Smith, Ph.D.

Johns Hopkins University School of Medicine

Using immunoSEQ® in the solid tumor setting

Theodore Scott Nowicki, MD, Ph.D.

University of California Los Angeles

Transgenic T-cell receptor adoptive cell therapies: addressing epigenetic suppression & optimizing therapies with immunosequencing

immunoSEQ Product Resources

Learn more about immunoSEQ Assay by downloading these helpful resources:

Contact us

Have Questions? Need to speak with someone?

Request information
Covid Icon Covid Icon
COVID-19 Applications

Learn how immunoSEQ® T-MAP™ COVID can help uncover the T-cell immune response in COVID-19.

Learn More
Library Icon Email Icon

Access technical documents for getting started with the immunoSEQ® Service product, grant writing support, and FAQs.

Learn More